Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer's disease mouse model.
He Y, Pan S, Xu M, He R, Huang W, Song P, Huang J, Zhang HT, Hu Y.
He Y, et al. Among authors: huang w, huang j.
FASEB J. 2017 Aug;31(8):3383-3392. doi: 10.1096/fj.201700064R. Epub 2017 Apr 18.
FASEB J. 2017.
PMID: 28420695
These findings provide a novel strategy to selectively target Cdk5 for the treatment of Alzheimer's disease.-He, Y., Pan, S., Xu, M., He, R., Huang, W., Song, P., Huang, J., Zhang, H.-T., Hu, Y. Adeno-associated virus 9-mediated Cdk5 inhibitory peptide revers …
These findings provide a novel strategy to selectively target Cdk5 for the treatment of Alzheimer's disease.-He, Y., Pan, S., Xu, M., He, R. …